Eris Launches Semaglutide Generic in India at $13.8/Month

Eris Lifesciences Launches Affordable Semaglutide Generic in India

Eris Lifesciences has launched one of India's most affordable generic versions of semaglutide, a popular diabetes treatment drug. The product, branded as Sundae, is priced as low as 1,290 rupees ($13.8) per month for its starting dose, signaling a significant shift in market dynamics.

Market Overview

The launch comes as Novo Nordisk's patent for semaglutide is set to expire on March 20, opening the door for numerous Indian drugmakers to enter the market. Eris Lifesciences, in partnership with Natco Pharma, is among the first movers, with major competitors like Dr Reddy’s Laboratories also expected to release their versions imminently. The initial launch includes a 2 mg vial, with a pen device version planned for April.

Economic and Market Impact

The introduction of low-cost generic semaglutide is poised to significantly disrupt the diabetes and weight-loss drug market in India. Sundae's entry price is approximately 88% cheaper than Novo Nordisk's Wegovy and 91% lower than Eli Lilly's Mounjaro on a monthly basis for the lowest dose. This aggressive pricing strategy will increase patient accessibility and intensify competition among pharmaceutical companies, potentially driving down overall treatment costs.

Summary

Eris Lifesciences' launch of Sundae marks a pivotal moment for India's pharmaceutical sector. The company plans to expand its offering with a pen device in April, featuring dosages up to 8 mg priced at 4,500 rupees per month. The market will be closely watching the response from competitors and the impact on pricing and market share for existing branded drugs.

FAQ

Q: What is the brand name of Eris Lifesciences' generic semaglutide?
A: The product is branded as Sundae in India.

Q: How does the price of Sundae compare to other brands?
A: Its lowest monthly dose is 1,290 rupees ($13.8), making it up to 91% cheaper than competing brands like Mounjaro.

Q: When will other versions of Sundae be available?
A: Eris plans to launch a pen device version with three different dosages in April.

Source: Investing.com